Genprex Inc (GNPX) Live Share Price, Invest From India

Genprex Inc Stock Performance

as on April 11, 2026 at 6:59 am IST

Day's High
$1.17
Day's Price Range
$1.34
$1.17
14.53%
Upside
52 Week's Low
52 Week's High
$1.15
52-Week Price Range
$55.00
$1.17
1.71%
Downside
4600.85%
Upside

Genprex Inc share price movements today

Previous Close: $1.30
Open: $1.30
Volume: 850.9K
Day's Low - High: $1.17 - $1.34
52 Week Low - High: $1.15 - $55.00

Genprex Inc Historical Returns

1 Month Return: -42.5 %
3 Month Return: -47.73 %
1 Year Return: -91.37 %
3 Year Return: -99.93 %
5 Year Return: -99.99 %

Genprex Inc Stock Fundamentals & Key Indicators

Check Genprex Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$11.8M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-15.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-338.74%

Genprex Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Genprex Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Genprex Inc	BUY	$11.8M	-99.99%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$42.6B	133.02%	140.91	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$113.6B	104.49%	29.16	32.94%
Beone Medicines Ltd	NA	$36.0B	NA	126.38	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$81.2B	57.6%	18.52	31.41%

Stock Returns calculator for Genprex Inc Stock including INR - Dollar returns

The Genprex Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Genprex Inc investment value today

Current value as on today

₹9,482

Returns

-₹90,518

(-90.52%)

Returns from Genprex Inc Stock

-₹91,216 (-91.22%)

Dollar Impact

₹698 (+0.70%)

Analyst Recommendation on Genprex Inc Stock

Based on 9 analysts

BUY

77.78%

Buy

22.22%

Hold

0.00%

Sell

Based on 9 analysts, 77.78% of analysts recommend a 'BUY' rating for Genprex Inc. Average target price of $7.5

Genprex Inc Share Price Target

Get share price movements and forecasts by analysts on Genprex Inc.

What analysts predicted

84.4%UPSIDE

Target Price

$7.5

Current Price

$1.17

Analyzed by

9 Analysts

Target

$7.50

Genprex Inc target price $7.5, a slight upside of 84.4% compared to current price of $1.17. According to 9 analysts rating.

Genprex Inc Stock’s Investor Sentiment and Interest

Search interest for Genprex Inc Stock has decreased by -58% in the last 30 days, reflecting a downward trend in search activity.

Time period: March 13, 2026 to April 12, 2026

Change:-58% versus previous 30 day period

Genprex Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	0	-	-	-	0	-	-	-
Gross Profit	0	-	0	0	0	-	0	-	-	-
Operating Income	-7	-5	-5	-6	-4	-4	-3	-4	-3	-3
EBITDA	-7	-	-5	-6	-4	-	-3	-4	-3	-3
Interest Expense	-	-	0	-	-	-	-	-	0	0
Depreciation	0	0	0	0	0	0	-	-	-	-
Income Before Tax	-7	-5	-5	-6	-4	-4	-3	-4	-3	-3
Income Tax Expense	0	-	0	0	-	-	-	-	-	-
Net Income	-7	-5	-5	-6	-4	-4	-3	-4	-3	-3
Net Profit Margin	0.00%	0.00%	-25779.00%	0.00%	0.00%	0.00%	-39981.86%	0.00%	0.00%	0.00%

Genprex Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	0	0	0	0	0	0	-
Operating Income	-4	-3	-12	-10	-17	-20	-23	-31	-21	-15
EBITDA	-4	-3	-12	-10	-17	-20	-23	-31	-21	-15
Interest Expense	-	0	0	0	-	0	18	-	-	0
Depreciation	-	0	0	0	0	0	0	0	0	-
Income Before Tax	-4	-3	-12	-10	-17	-20	-23	-30	-21	-16
Income Tax Expense	-	0	0	0	0	0	5	0	-21,367	-
Net Income	-4	-3	-12	-10	-17	-20	-23	-30	-21	-16
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Genprex Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-5	-5	-6	-4	-4	-3	-4	-3	-3
Operating Cash Flow	-4	-5	-5	-1	-3	-4	-3	-3	-4
Investing Cash Flow	-	0	0	0	-	0	-	-	-
Financing Cash Flow	0	6	0	1	3	6	1	2	10
Change in Cash	-4	1	-5	0	0	1	-2	0	6

Genprex Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-3	-12	-10	-17	-19	-23	-30	-21	-16
Operating Cash Flow	-2	-6	-6	-13	-14	-17	-24	-17	-15
Investing Cash Flow	0	0	0	-2	0	0	0	0	-
Financing Cash Flow	0	15	1	41	25	0	10	12	21
Change in Cash	-1	8	-6	25	11	-17	-14	-5	6

Global Institutional Holdings in Genprex Inc

Funds	Holdings
Citigroup Inc	0.01%
Morgan Stanley - Brokerage Accounts	0%
Royal Bank of Canada	0%
FMR Inc	0%
Group One Trading, LP	0%

See all

Insights on Genprex Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 58.8% return, outperforming this stock by 158.7%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 126.9%
NEGATIVE IMPACT
Price Dip
In the last 7 days, GNPX stock has moved down by -25.3%

About Genprex Inc

genprex is mapping the future of cancer care. genprex's mission is to address the unmet medical needs of a growing population of cancer patients worldwide, through the development of a novel class of cancer drugs: immunogene therapy. our revolutionary clinical-stage products work synergistically with other approved and pipeline drugs to expand clinical indications for various cancers. about oncoprex® and lung cancer lung cancer is the second most common cancer in the u.s. but the leading cause of cancer death. there are approximately 225,000 new lung cancer cases in the u.s. per year and 1.8 million worldwide. the 5-year survival rate of stage iv non-small cell lung cancer (nsclc) is less than 1%, and treatment options beyond chemotherapy are lacking. approved nsclc targeted treatment options outside of chemo/radiation therapies only benefit a minority of patients. oncoprex® may now fill that gap by offering a targeted treatment option for a majority of nsclc patients. oncoprex® is cur

Organisation	Genprex Inc
Headquarters	3300 Bee Cave Road, Austin, TX, United States, 78746
Industry	Health Technology
CEO	Mr. Ryan M. Confer M.S.
E-voting on shares	Click here to vote

Key Management of Genprex Inc

Name	Title
Dr. Jack A. Roth F.A.C.S., M.D.	Chairman of Scientific & Medical Advisory Board
Mr. Ryan M. Confer M.S.	President, CEO, CFO & Director
Dr. Mark S. Berger M.D.	Chief Medical Officer
Mr. David M. Schloss	Senior Vice President of Human Resources
Mr. Thomas C. Gallagher Esq.	Senior Vice President of Intellectual Property & Licensing
Dr. Suzanne Thornton-Jones Ph.D.	Senior Vice President of Regulatory Affairs & Quality
Ms. Celina Laney	Chief of Staff

FAQs

What is Genprex Inc share price today?

Genprex Inc share price today is $1.17 as on April 11, 2026 at 1:29 am IST at the close of the market. Genprex Inc share today touched a day high of $1.34 and a low of $1.17.

What is the 52 week high and 52 week low for Genprex Inc share?

Genprex Inc share touched a 52 week high of $55 on October 15, 2025 and a 52 week low of $1.15 on April 10, 2026. Genprex Inc stock price today i.e. April 11, 2026 at 1:29 am IST is closed at $1.17,which is 97.87% down from its 52 week high and 1.74% up from its 52 week low.

What is Genprex Inc's market capitalisation today?

Genprex Inc market capitalisation is $0.00T as on April 11, 2026 at 1:29 am IST.

How to invest in Genprex Inc Stock (GNPX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Genprex Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Genprex Inc Shares that will get you 1.2821 shares as per Genprex Inc share price of $1.17 per share as on April 11, 2026 at 1:29 am IST.

What is the minimum amount required to buy Genprex Inc Stock (GNPX) from India?

Indian investors can start investing in Genprex Inc (GNPX) shares with as little as ₹93.048 or $1 (as of April 12, 2026 at 3:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹930.48 in Genprex Inc stock (as per the Rupee-Dollar exchange rate as on April 12, 2026 at 3:38 pm IST). Based on Genprex Inc share’s latest price of $1.17 as on April 11, 2026 at 1:29 am IST, you will get 8.5470 shares of Genprex Inc. Learn more about fractional shares .

What are the returns that Genprex Inc has given to Indian investors in the last 5 years?

Genprex Inc stock has given -99.99% share price returns and 23.46% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?